BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26872393)

  • 1. The cost-effectiveness of training US primary care physicians to conduct colorectal cancer screening in family medicine residency programs.
    Edwardson N; Bolin JN; McClellan DA; Nash PP; Helduser JW
    Prev Med; 2016 Apr; 85():98-105. PubMed ID: 26872393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of screening the average-risk population for colorectal cancer.
    Provenzale D
    Gastrointest Endosc Clin N Am; 2002 Jan; 12(1):93-109. PubMed ID: 11916165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of patient mailings to promote colorectal cancer screening.
    Sequist TD; Franz C; Ayanian JZ
    Med Care; 2010 Jun; 48(6):553-7. PubMed ID: 20473196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of screening for colorectal cancer in the general population.
    Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
    JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
    Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
    Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of a standard intervention versus a navigated intervention on colorectal cancer screening use in primary care.
    Lairson DR; Dicarlo M; Deshmuk AA; Fagan HB; Sifri R; Katurakes N; Cocroft J; Sendecki J; Swan H; Vernon SW; Myers RE
    Cancer; 2014 Apr; 120(7):1042-9. PubMed ID: 24435411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History.
    Cenin DR; Naber SK; de Weerdt AC; Jenkins MA; Preen DB; Ee HC; O'Leary PC; Lansdorp-Vogelaar I
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):10-21. PubMed ID: 31748260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of colorectal cancer screening - an overview.
    Lansdorp-Vogelaar I; Knudsen AB; Brenner H
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):439-49. PubMed ID: 20833348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening based on risk for colorectal cancer is the most cost-effective approach.
    Dan YY; Chuah BY; Koh DC; Yeoh KG
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):266-71.e1-6. PubMed ID: 22100624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal Cancer Screening Based on Age and Gender: A Cost-Effectiveness Analysis.
    Wong MCS; Ching JYL; Chan VCW; Lam TYT; Luk AKC; Wong SH; Ng SC; Ng SSM; Wu JCY; Chan FKL; Sung JJY
    Medicine (Baltimore); 2016 Mar; 95(10):e2739. PubMed ID: 26962772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening.
    van Gils P; van den Berg M; van Kranen H; de Wit AG
    Eur J Cancer; 2009 Jun; 45(9):1554-9. PubMed ID: 19261464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates of costs and effects of screening for colorectal cancer in the United States.
    Byers T; Gorsky R
    Cancer; 1992 Sep; 70(5 Suppl):1288-95. PubMed ID: 1387342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of a patient navigation intervention to increase colonoscopy screening among low-income adults in New Hampshire.
    Rice K; Sharma K; Li C; Butterly L; Gersten J; DeGroff A
    Cancer; 2019 Feb; 125(4):601-609. PubMed ID: 30548480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
    Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
    Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of colorectal cancer screening programs: Affordability for the health service.
    Coretti S; Ruggeri M; Dibidino R; Gitto L; Marcellusi A; Mennini FS; Cicchetti A
    J Med Screen; 2020 Dec; 27(4):186-193. PubMed ID: 31948342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.
    Ladabaum U; Allen J; Wandell M; Ramsey S
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1567-76. PubMed ID: 23796793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.